OBJECTIVES:
To evaluate factors predictive of post-discharge opioid prescription refills after female pelvic reconstructive surgery. MATERIALS AND METHODS: After IRB approval, a retrospective chart review using electronic medical records was performed on patients who underwent surgery within the academic urogynecology practice from January 1, 2018, to June 30, 2018, inclusive. The number of patients who needed a narcotic refill in the postoperative period (within eight weeks of surgery) was determined. Demographic information, patient and surgical factors, including information on narcotic use during the hospital stay were compared between patients who received refills vs. patient who did not. Calls during the postoperative period were tabulated. All narcotic information was converted to mg equivalent oral morphine (MME). Continuous data were evaluated with a Student's t-test or ANOVA; categorical data were evaluated with a chi square test. Results yielding p<0.05 were deemed statistically significant. RESULTS: Two hundred sixty-five patients underwent pelvic reconstructive surgery in the designated period, of which 262 records were included in this study. Seventeen (6.5%) patients received a narcotic prescription refill. Refill recipients received more intravenous (IV) (p¼0.001) and oral (PO) (p¼0.007) in-hospital narcotics compared to those who did not. Patients who were narcotic non-users in the hospital were less likely to require a refill post-discharge (p¼0.016). There was no statistical difference in any other demographic, clinical or surgical factors between patients who received refills vs. patients who did not. CONCLUSION: The demand for opioid prescriptions refills after pelvic reconstructive surgery is low. Amount of in-hospital postoperative narcotic use can be a valuable predictor of patients needing additional opioid prescriptions post-discharge. Prospective studies are warranted to evaluate definitive factors that predict patients requiring opioid prescription refills post-discharge. 
MATERIALS AND METHODS:
Retrospective cohort of USLS procedures performed at the time of hysterectomy at a tertiary care center over a three-year period. Patient demographics, surgical data, concomitant adnexal procedures, and complications were abstracted from a surgical database and compared using parametric or non-parametric tests as appropriate. Validated questionnaires (POPDI-6, UDI-6, PROMIS) were used to collect information on recurrence and longterm complications. Patients were analyzed both according to attention to treat analysis based on intended approach and by completed route of surgery to deal with intra-operative conversions. RESULTS: Two hundred six patients met criteria for inclusion, 152 underwent vaginal USLS (V-USLS) and 54 laparoscopic USLS (L-USLS). No statistically significant differences in mean case time, post-operative length of stay or peri-op infection was found. While no ureteric obstructions occurred in the L-USLS group, in the V-USLS 14 (9%) obstructions occurred (p¼0.023). Post-operative urinary retention was higher with V-USLS (31% vs 15%, p¼0.024). Rates of successfully completed adnexal surgery differed (56% vs 98%, p<0.001) in favor of L-USLS. Patient reported symptomatic recurrence of prolapse was higher in the V-USLS group (41% vs. 24%, p¼0.046); despite this re-treatment did not differ between the groups (0% vs. 7%, p¼0.113). CONCLUSION: Laparoscopic uterosacral vault suspension offered higher rates of patient reported cure, lower rates of intra-operative ureteric kinking, lower rates of failing institutional post-op bladder protocol, and higher rates of successful concomitant adnexal surgery without incurring longer total operative case times or higher rates of vascular or visceral injury. These differences may influence surgical decision making in terms of which approach to choose when performing uterosacral vault suspension at the time of hysterectomy. 
